220 related articles for article (PubMed ID: 26992634)
1. Rituximab usage in systemic lupus erythematosus-associated antiphospholipid syndrome: A single-center experience.
Wang CR; Liu MF
Semin Arthritis Rheum; 2016 Aug; 46(1):102-8. PubMed ID: 26992634
[TBL] [Abstract][Full Text] [Related]
2. Catastrophic antiphospholipid syndrome associated with systemic lupus erythematosus treated with rituximab: case report and a review of the literature.
Sukara G; Baresic M; Sentic M; Brcic L; Anic B
Acta Reumatol Port; 2015; 40(2):169-75. PubMed ID: 25782914
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
4. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
5. Microthrombotic renal involvement in an SLE patient with concomitant catastrophic antiphospholipid syndrome: the beneficial effect of rituximab treatment.
Diószegi Á; Tarr T; Nagy-Vincze M; Nánásy-Vass M; Veisz R; Bidiga L; Dezső B; Balla J; Szodoray P; Szekanecz Z; Soltész P
Lupus; 2018 Aug; 27(9):1552-1558. PubMed ID: 29635999
[TBL] [Abstract][Full Text] [Related]
6. Successful Treatment of Catastrophic Antiphospholipid Syndrome Using Rituximab: Case Report and Review of the Literature.
Stanescu C; Andronesi AG; Jurcut C; Gherghiceanu M; Vornicu A; Burcea FA; Andronesi TD; Lupusoru GE; Iliuta L; Sorohan BM; Obrisca B; Ismail G
Medicina (Kaunas); 2021 Aug; 57(9):. PubMed ID: 34577835
[TBL] [Abstract][Full Text] [Related]
7. The use of fondaparinux and rituximab for recurrent thrombotic events in antiphospholipid syndrome.
Sayar Z; Burke S; Mittal P; Cohen H
Lupus; 2022 Oct; 31(12):1485-1490. PubMed ID: 36074077
[TBL] [Abstract][Full Text] [Related]
8. Superficial vein thrombosis, thrombin generation and activated protein C resistance as predictors of thromboembolic events in lupus and antiphospholipid patients. A prospective cohort study.
Zuily S; Regnault V; Guillemin F; Kaminsky P; Rat AC; Lecompte T; Wahl D
Thromb Res; 2013 Jul; 132(1):e1-7. PubMed ID: 23676348
[TBL] [Abstract][Full Text] [Related]
9. Non-thromboembolic risk in systemic lupus erythematosus associated with antiphospholipid syndrome.
Deák M; Bocskai M; Burcsár S; Dányi O; Fekete Z; Kovács L
Lupus; 2014 Aug; 23(9):913-8. PubMed ID: 24729279
[TBL] [Abstract][Full Text] [Related]
10. High impact of antiphospholipid syndrome on irreversible organ damage and survival of patients with systemic lupus erythematosus.
Ruiz-Irastorza G; Egurbide MV; Ugalde J; Aguirre C
Arch Intern Med; 2004 Jan; 164(1):77-82. PubMed ID: 14718326
[TBL] [Abstract][Full Text] [Related]
11. The management of thrombosis in the antiphospholipid-antibody syndrome.
Khamashta MA; Cuadrado MJ; Mujic F; Taub NA; Hunt BJ; Hughes GR
N Engl J Med; 1995 Apr; 332(15):993-7. PubMed ID: 7885428
[TBL] [Abstract][Full Text] [Related]
12. Determinants of risk for venous and arterial thrombosis in primary antiphospholipid syndrome and in antiphospholipid syndrome with systemic lupus erythematosus.
Danowski A; de Azevedo MN; de Souza Papi JA; Petri M
J Rheumatol; 2009 Jun; 36(6):1195-9. PubMed ID: 19447935
[TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of rituximab in the treatment of primary antiphospholipid syndrome: analysis of 24 cases from the bibliography review].
Pons I; Espinosa G; Cervera R
Med Clin (Barc); 2015 Feb; 144(3):97-104. PubMed ID: 24698717
[TBL] [Abstract][Full Text] [Related]
14. Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles.
Huong DL; Wechsler B; Vauthier-Brouzes D; Duhaut P; Costedoat N; Lefebvre G; Piette JC
Semin Arthritis Rheum; 2002 Dec; 32(3):174-88. PubMed ID: 12528082
[TBL] [Abstract][Full Text] [Related]
15. Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
Perez-Sanchez C; Barbarroja N; Messineo S; Ruiz-Limon P; Rodriguez-Ariza A; Jimenez-Gomez Y; Khamashta MA; Collantes-Estevez E; Cuadrado MJ; Aguirre MA; Lopez-Pedrera C
Ann Rheum Dis; 2015 Jul; 74(7):1441-9. PubMed ID: 24618261
[TBL] [Abstract][Full Text] [Related]
16. Severe thrombotic events associated with pre-procedural interruption of anticoagulation in systemic lupus erythematosus with secondary antiphospholipid syndrome: Cases and literature review.
Anderson M; Belmont HM
Lupus; 2022 Feb; 31(2):261-267. PubMed ID: 35041558
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and pattern of antiphospholipid antibody syndrome in a hospital based longitudinal study of 193 patients of systemic lupus erythematosus.
Singh NK; Agrawal A; Singh MN; Kumar V; Godhra M; Gupta A; Yadav DP; Usha ; Singh RG; Singh TB
J Assoc Physicians India; 2013 Sep; 61(9):623-6. PubMed ID: 24772699
[TBL] [Abstract][Full Text] [Related]
18. Thin-section chest CT findings in systemic lupus erythematosus with antiphospholipid syndrome: a comparison with systemic lupus erythematosus without antiphospholipid syndrome.
Oki H; Aoki T; Saito K; Yamashita Y; Hanamiya M; Hayashida Y; Tanaka Y; Korogi Y
Eur J Radiol; 2012 Jun; 81(6):1335-9. PubMed ID: 21501937
[TBL] [Abstract][Full Text] [Related]
19. Hemorrhagic complications of long-term anticoagulant therapy in 7 patients with systemic lupus erythematosus and antiphospholipid syndrome.
al-Sayegh FA; Ensworth S; Huang S; Stein HB; Klinkhoff AV
J Rheumatol; 1997 Sep; 24(9):1716-8. PubMed ID: 9292793
[TBL] [Abstract][Full Text] [Related]
20. Pelvic deep venous thrombosis mimicking lower limb cellulitis in systemic lupus erythematosus-associated antiphospholipid syndrome.
Wang CR; Lee CH
Lupus; 2022 Apr; 31(5):613-618. PubMed ID: 35293251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
